SP
BravenNow
Plus Therapeutics appoints Ronald A. Andrews to board following director resignation
| USA | economy | ✓ Verified - investing.com

Plus Therapeutics appoints Ronald A. Andrews to board following director resignation

📚 Related People & Topics

Plus Therapeutics

Plus Therapeutics

U.S. healthcare company

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system (CNS) cancers. The company’s lead therapeutic candidate, marketed as REYOBIQ™ (rhenium Re-186 obis...

View Profile → Wikipedia ↗

Entity Intersection Graph

Connections for Plus Therapeutics:

🌐 SEC filing 1 shared
🏢 Chief business development officer 1 shared
👤 Eric Daniels 1 shared
View full profile

Mentioned Entities

Plus Therapeutics

Plus Therapeutics

U.S. healthcare company

}

Source

investing.com

More from USA

News from Other Countries

🇬🇧 United Kingdom

🇺🇦 Ukraine